Nami Yamashita

8PUBLICATIONS
57CO-AUTHORS
Organisational, interpersonal and intercultural communicationModels of care and place of birthCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 31, 2026
Social Media Discourse on Breast Cancer Screening Barriers in Japanese and English: Cross-Sectional Infodemiology Study.

|Dec 05, 2025
Retrospective analysis of survival of patients with HER2-positive breast cancer with microscopic residual invasive disease after neoadjuvant chemotherapy.

Meiko Nishimura, Takayuki Kobayashi, Yosuke Aoyama

|Dec 07, 2024
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world study.

Yosuke Aoyama, Yukinori Ozaki, Rika Kizawa

|Apr 15, 2024
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.

Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya

|Nov 23, 2023
A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancer.

Asumi Iesato, Atsushi Fushimi, Rie Tahara

|Nov 29, 2022
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer.

Nami Yamashita, Yoshihiro Morimoto, Atsushi Fushimi

Pageof 2

Frequent Collaborators

5 joint publications

Atsushi Fushimi

4 joint publications

Donald Kufe

3 joint publications

Atrayee Bhattacharya

3 joint publications

Yoshihiro Morimoto